Key facts
- Capstan Medical’s last known valuation is $367.0M (Dec 2024).
- It has raised $152.8M; the latest was Later Stage VC ($110.0M) in Dec 2024.
- Notable investors include Eclipse Capital, Eclipse Ventures, Puma Venture Capital, Gideon Strategic Partners, Intuitive Ventures — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Capstan Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Capstan Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Capstan Medical
Developer of catheter-based technology intended to transform the treatment of structural heart disease. The company offers a less invasive alternative to traditional open heart surgery while ensuring precise and reliable placement of the heart valve implant, enabling doctors to give their patients a solution to their heart valve disease while significantly reducing recovery time and minimizing the risk of complications
- Sector
- Healthcare
- HQ
- Santa Cruz, CA, United States
- Founded
- 2020
- Employees
- 69
- Website
- capstanmedical.com/
- Ownership
- Privately Held (backing)
Capstan Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Capstan Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Capstan Medical in its N-PORT filings yet. We sweep new filings monthly.